Lifebridge Medizintechnik AG is an innovative medical-engineering company engaged in developing, producing and marketing life-saving support systems which apply state-of-the-art technologies to extracorporeal circulation.

The company's flagship product, Lifebridge B2T® is a miniaturized and compact heart-lung machine (HLM) that can be made ready for use in 10% of the time needed for traditional HLMs, weighs 15% of current HLMs and will be available for 20% of the cost of today's machines. This revolutionary product will bring immediate heart and lung assistance to patients suffering from acute cardio circulatory failure and improve their chances of survival.

The group of investors led by Injaz Mena holds a 16% stake in the company.

Injaz Mena and its co-investors hold a 12% shareholding in Lifebridge Medizintechnik AG, a German medical engineering company established in 1999 that has developed a patented miniaturized heart-lung machine that is expected to become a world standard in emergency life support systems. European regulatory approvals were gained in 2006 and the machines are now in use in hospitals and clinics in Europe. The global launch will follow FDA approval in the USA which is now in progress.
The Lifebridge heart-lung machine is portable, simple to operate and low cost (about a fifth of the price of conventional machines).